Benjamin F. Edwards & Company’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Benjamin F. Edwards & Company’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-33	Closed	-$2K	–	1176
2015 Q4	$2K	Hold	33	–	–	﹤0.01%	1079
2015 Q3	$2K	Hold	33	–	–	﹤0.01%	1077
2015 Q2	$3K	Hold	33	–	–	﹤0.01%	1082
2015 Q1	$3K	Hold	33	–	–	﹤0.01%	1040
2014 Q4	$2K	Hold	33	–	–	﹤0.01%	965
2014 Q3	$2K	Hold	33	–	–	﹤0.01%	934
2014 Q2	$2K	Hold	33	–	–	﹤0.01%	885
2014 Q1	$2K	Hold	33	–	–	﹤0.01%	848
2013 Q4	$2K	Hold	33	–	–	﹤0.01%	877
2013 Q3	$2K	Hold	33	–	–	﹤0.01%	777
2013 Q2	$1K	Buy	+33	New	+$1.37K	﹤0.01%	771

Other funds holding PJP

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

SCM

Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

Benjamin F. Edwards & Company's PJP Position: Q1 2016 in Review

Benjamin F. Edwards & Company sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2016, closing a stake of 33 shares — an estimated $2K sold.

Benjamin F. Edwards & Company first reported a position in PJP in Q2 2013 and held it in 11 quarters. The position peaked at $3K in Q2 2015. 93 funds tracked by Wall St. Rank hold PJP as of Q1 2016.

Benjamin F. Edwards & Company reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
Benjamin F. Edwards & Company sold 33 Invesco Pharmaceuticals ETF shares in Q1 2016, an estimated $2K.
Benjamin F. Edwards & Company first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 11 quarters.
Benjamin F. Edwards & Company's Invesco Pharmaceuticals ETF position peaked at $3K in Q2 2015.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2016.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2016, filed 13 Apr 2016.